A detailed history of Voloridge Investment Management, LLC transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Voloridge Investment Management, LLC holds 2,590,861 shares of BCRX stock, worth $21.8 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
2,590,861
Previous 967,722 167.73%
Holding current value
$21.8 Million
Previous $4.92 Million 225.69%
% of portfolio
0.06%
Previous 0.02%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$4.13 - $6.79 $6.7 Million - $11 Million
1,623,139 Added 167.73%
2,590,861 $16 Million
Q1 2024

May 15, 2024

SELL
$4.89 - $7.65 $557,088 - $871,518
-113,924 Reduced 10.53%
967,722 $4.92 Million
Q4 2023

Feb 14, 2024

BUY
$4.98 - $6.77 $3.67 Million - $4.99 Million
737,798 Added 214.57%
1,081,646 $6.48 Million
Q3 2023

Nov 14, 2023

BUY
$6.71 - $7.92 $1.69 Million - $2 Million
252,451 Added 276.21%
343,848 $2.43 Million
Q2 2023

Aug 14, 2023

SELL
$6.96 - $8.81 $4.05 Million - $5.13 Million
-581,868 Reduced 86.42%
91,397 $643,000
Q1 2023

May 15, 2023

BUY
$7.94 - $11.84 $3.24 Million - $4.83 Million
408,048 Added 153.85%
673,265 $5.62 Million
Q4 2022

Feb 14, 2023

BUY
$10.5 - $14.2 $2.78 Million - $3.77 Million
265,217 New
265,217 $3.04 Million
Q2 2022

Aug 15, 2022

SELL
$7.89 - $17.88 $1.01 Million - $2.28 Million
-127,510 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$11.56 - $19.76 $6.55 Million - $11.2 Million
-566,320 Reduced 81.62%
127,510 $2.07 Million
Q4 2021

Feb 14, 2022

SELL
$11.18 - $15.46 $5.44 Million - $7.52 Million
-486,467 Reduced 41.22%
693,830 $9.61 Million
Q3 2021

Nov 15, 2021

BUY
$14.21 - $17.65 $8.64 Million - $10.7 Million
607,919 Added 106.21%
1,180,297 $17 Million
Q2 2021

Aug 16, 2021

BUY
$9.5 - $17.24 $5.44 Million - $9.87 Million
572,378 New
572,378 $9.05 Million
Q1 2021

May 17, 2021

SELL
$7.37 - $13.61 $7.66 Million - $14.1 Million
-1,038,874 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$3.37 - $8.61 $3.5 Million - $8.94 Million
1,038,874 New
1,038,874 $7.74 Million
Q4 2019

Feb 14, 2020

SELL
$1.59 - $3.45 $56,677 - $122,978
-35,646 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$2.5 - $3.73 $236,635 - $353,059
-94,654 Reduced 72.64%
35,646 $102,000
Q2 2019

Aug 14, 2019

BUY
$2.91 - $9.15 $342,783 - $1.08 Million
117,795 Added 941.98%
130,300 $494,000
Q1 2019

May 15, 2019

BUY
$7.38 - $9.72 $92,286 - $121,548
12,505 New
12,505 $102,000

Others Institutions Holding BCRX

About BIOCRYST PHARMACEUTICALS INC


  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.57B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track Voloridge Investment Management, LLC Portfolio

Follow Voloridge Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.